サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1743525

動物用薬剤コンパウンディングの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測

Global Animal Drug Compounding Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 234 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.12円
動物用薬剤コンパウンディングの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測
出版日: 2025年06月01日
発行: Value Market Research
ページ情報: 英文 234 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

動物用薬剤コンパウンディングの世界市場規模は、2024年の28億5,000万米ドルから2033年には61億6,000万米ドルに成長し、2026年から2033年の予測期間中に8.93%のCAGR（複合年間成長率）を示すと予測されています。

動物用薬剤コンパウンディング剤市場は、個別化された獣医学的治療に対する需要の高まりと、ペットや家畜の慢性疾患の有病率の増加により、顕著な急成長を遂げています。ペットの飼育率が上昇し、動物の健康に対する意識が高まるにつれ、獣医師は個々の動物の特定のニーズを満たすオーダーメイドの薬を作るために、ますます調剤薬局を利用するようになっています。この動向は、市販されている薬が用量、製剤、風味の好みなどの理由で適さない場合に特に顕著です。薬をカスタマイズする能力は治療効果とコンプライアンスを向上させ、動物用薬剤コンパウンディング市場を現代の獣医診療に不可欠な要素として位置づけています。

さらに、製薬技術と規制の枠組みの進歩が、動物用薬剤コンパウンディング市場の成長を促進しています。より厳格な品質基準とガイドラインの導入により、配合薬の安全性、有効性、信頼性が確保されています。獣医の専門家が調合薬の利点について知識を深めるにつれて、市場は拡大し、調合サービスを取り入れる獣医診療所が増加すると考えられます。さらに、動物医療における遠隔医療の台頭は、調剤薬局がより幅広い顧客層にアプローチする新たな機会を生み出し、遠隔地での診察やカスタマイズされた投薬の提供を可能にしています。

動物用薬剤コンパウンディング市場では、薬剤の嗜好性と有効性を高める新しいデリバリー方法の開発に重点を置いた、製剤技術の革新も見られます。香味剤の配合、経皮投与システム、徐放性製剤などは、動物用医薬品の進化するニーズを満たすために調剤薬局がどのように適応しているかを示すほんの一例に過ぎないです。消費者の需要、技術の進歩、規制当局のサポートが相まって市場が成長し続ける中、動物用薬剤コンパウンディングの将来は、動物の健康と幸福を保証し、ケアの質を高めることを約束します。

当社のレポートは、様々な産業や市場に関する包括的かつ実用的な洞察をお客様に提供するために、細心の注意を払って作成されています。各レポートには、市場情勢を完全に理解するためのいくつかの重要な要素が含まれています：

市場概要：定義、分類、業界の現状など、市場に関する詳細なイントロダクション。

市場力学：市場成長に影響を与える主な促進要因・抑制要因・機会・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場プレイヤーの包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を提供します。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測します。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域ごとの市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネスチャンスを理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象分野を特定します。将来の市場開拓と成長見通しに関する洞察を提供します。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 動物用薬剤コンパウンディング業界の分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 動物用薬剤コンパウンディングの世界市場分析：動物タイプ別

  • 概要
  • 過去および予測データ分析
  • コンパニオンアニマル
  • 畜産動物

第6章 動物用薬剤コンパウンディングの世界市場分析：薬剤タイプ別

  • 概要
  • 過去および予測データ分析
  • 抗感染症薬
  • 抗炎症剤
  • ホルモン・代用薬
  • 中枢神経系薬剤
  • その他の薬剤タイプ

第7章 動物用薬剤コンパウンディングの世界市場分析：剤形別

  • 概要
  • 過去および予測データ分析
  • 経口剤（錠剤、カプセル剤、液剤、その他の経口剤）
  • 局所用（軟膏、クリーム、ゲル、スプレー）
  • 注射剤
  • その他の剤形

第8章 動物用薬剤コンパウンディングの世界市場分析：流通チャネル別

  • 概要
  • 過去および予測データ分析
  • 動物病院薬局
  • コンパウンディング薬局
  • その他の流通チャネル

第9章 動物用薬剤コンパウンディングの世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州セグメント別
    • 欧州国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域売上分析
    • 概要、実績と予測
    • アジア太平洋地域セグメント別
    • アジア太平洋地域国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋地域
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカセグメント別
    • ラテンアメリカ国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカセグメント別
    • 中東・アフリカ国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第10章 動物用薬剤コンパウンディング企業の競合情勢

  • 動物用薬剤コンパウンディング市場競合
  • 提携・協力・合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第11章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • AVRIO Pharmacy
  • New Era Pharmacy
  • NexGen Pharmaceuticals
  • Pace Pharmacy
  • SaveWay Compounding Pharmacy
  • ScriptWorks
  • SCIRx Pharmacy
  • Summit Veterinary Pharmacy Ltd.
  • Triangle Compounding Pharmacy
  • The Pet Apothecary
  • Veterinary Pharmaceutical Solutions
  • Veterinary Specialty Pharmacy
  • Wedgewood Pharmacy
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Animal Type (Revenue and USD MN)
  • Companion Animals Market Sales By Geography (Revenue and USD MN)
  • Livestock Animals Market Sales By Geography (Revenue and USD MN)
  • Analysis By Drug Type (Revenue and USD MN)
  • Anti-Infective Agents Market Sales By Geography (Revenue and USD MN)
  • Anti-Inflammatory Agents Market Sales By Geography (Revenue and USD MN)
  • Hormones & Substitutes Market Sales By Geography (Revenue and USD MN)
  • CNS Agents Market Sales By Geography (Revenue and USD MN)
  • Other Drug Types Market Sales By Geography (Revenue and USD MN)
  • Analysis By Dosage Form (Revenue and USD MN)
  • Oral (Tablets, Capsules, Liquids, Other Oral Dosage Forms) Market Sales By Geography (Revenue and USD MN)
  • Topical (Ointments, Creams, Gels, Sprays) Market Sales By Geography (Revenue and USD MN)
  • Injectable Market Sales By Geography (Revenue and USD MN)
  • Other Dosage Forms Market Sales By Geography (Revenue and USD MN)
  • Analysis By Distribution Channel (Revenue and USD MN)
  • Veterinary Hospitals Pharmacies Market Sales By Geography (Revenue and USD MN)
  • Compounding Pharmacies Market Sales By Geography (Revenue and USD MN)
  • Other Distribution Channels Market Sales By Geography (Revenue and USD MN)
  • Global Animal Drug Compounding Market Sales By Geography (Revenue and USD MN)
  • North America Market Analysis (Revenue and USD MN)
  • United States Market Analysis (Revenue and USD MN)
  • Canada Market Analysis (Revenue and USD MN)
  • Mexico Market Analysis (Revenue and USD MN)
  • Europe Market Analysis (Revenue and USD MN)
  • Europe Market Estimate By Country (Revenue and USD MN)
  • United Kingdom Market Analysis (Revenue and USD MN)
  • France Market Analysis (Revenue and USD MN)
  • Germany Market Analysis (Revenue and USD MN)
  • Italy Market Analysis (Revenue and USD MN)
  • Russia Market Analysis (Revenue and USD MN)
  • Spain Market Analysis (Revenue and USD MN)
  • Rest of Europe Market Analysis (Revenue and USD MN)
  • Asia Pacific Market Analysis (Revenue and USD MN)
  • China Market Analysis (Revenue and USD MN)
  • Japan Market Analysis (Revenue and USD MN)
  • India Market Analysis (Revenue and USD MN)
  • South Korea Market Analysis (Revenue and USD MN)
  • Australia Market Analysis (Revenue and USD MN)
  • South East Asia Market Analysis (Revenue and USD MN)
  • Rest of Asia Pacific Market Analysis (Revenue and USD MN)
  • Latin America Market Analysis (Revenue and USD MN)
  • Brazil Market Analysis (Revenue and USD MN)
  • Argentina Market Analysis (Revenue and USD MN)
  • Peru Market Analysis (Revenue and USD MN)
  • Chile Market Analysis (Revenue and USD MN)
  • Rest of Latin America Market Analysis (Revenue and USD MN)
  • Middle East & Africa Market Analysis (Revenue and USD MN)
  • Saudi Arabia Market Analysis (Revenue and USD MN)
  • UAE Market Analysis (Revenue and USD MN)
  • Israel Market Analysis (Revenue and USD MN)
  • South Africa Market Analysis (Revenue and USD MN)
  • Rest of Middle East and Africa Market Analysis (Revenue and USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Animal Drug Compounding Report
  • Market Research Process
  • Market Research Methodology
  • Global Animal Drug Compounding Market Size, By Regions (Revenue and USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Animal Type
  • Market Attractiveness Analysis By Drug Type
  • Market Attractiveness Analysis By Dosage Form
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Regions
  • Value Chain Analysis
  • Global Market Analysis By Animal Type (Revenue and USD MN)
  • Companion Animals Market Sales By Geography (Revenue and USD MN)
  • Livestock Animals Market Sales By Geography (Revenue and USD MN)
  • Global Market Analysis By Drug Type (Revenue and USD MN)
  • Anti-Infective Agents Market Sales By Geography (Revenue and USD MN)
  • Anti-Inflammatory Agents Market Sales By Geography (Revenue and USD MN)
  • Hormones & Substitutes Market Sales By Geography (Revenue and USD MN)
  • CNS Agents Market Sales By Geography (Revenue and USD MN)
  • Other Drug Types Market Sales By Geography (Revenue and USD MN)
  • Global Market Analysis By Dosage Form (Revenue and USD MN)
  • Oral (Tablets, Capsules, Liquids, Other Oral Dosage Forms) Market Sales By Geography (Revenue and USD MN)
  • Topical (Ointments, Creams, Gels, Sprays) Market Sales By Geography (Revenue and USD MN)
  • Injectable Market Sales By Geography (Revenue and USD MN)
  • Other Dosage Forms Market Sales By Geography (Revenue and USD MN)
  • Global Market Analysis By Distribution Channel (Revenue and USD MN)
  • Veterinary Hospitals Pharmacies Market Sales By Geography (Revenue and USD MN)
  • Compounding Pharmacies Market Sales By Geography (Revenue and USD MN)
  • Other Distribution Channels Market Sales By Geography (Revenue and USD MN)
  • Global Market Sales (Revenue and USD MN)
  • North America Market Sales (Revenue and USD MN)
  • Europe Market Sales (Revenue and USD MN)
  • Asia Pacific Market Sales (Revenue and USD MN)
  • Latin America Market Sales (Revenue and USD MN)
  • Middle East & Africa Market Sales (Revenue and USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11215051

Global Animal Drug Compounding Market size is anticipated to grow from USD 2.85 Billion in 2024 to USD 6.16 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 8.93% during the forecast period of 2026 to 2033.

The animal drug compounding market is experiencing a notable surge, driven by the increasing demand for personalized veterinary care and the growing prevalence of chronic diseases in pets and livestock. As pet ownership rises and animal health awareness grows, veterinarians are increasingly turning to compounding pharmacies to create tailored medications that meet the specific needs of individual animals. This trend is particularly significant in cases where commercially available drugs may not be suitable due to dosage, formulation, or flavor preferences. The ability to customize medications enhances treatment efficacy and compliance, positioning the animal drug compounding market as a vital component of modern veterinary practice.

Furthermore, advancements in pharmaceutical technology and regulatory frameworks are facilitating the growth of the animal drug compounding market. The introduction of more stringent quality standards and guidelines is ensuring that compounded medications are safe, effective, and reliable. As veterinary professionals become more educated about the benefits of compounded drugs, the market is likely to expand, with an increasing number of veterinary practices incorporating compounding services into their offerings. Additionally, the rise of telemedicine in veterinary care is creating new opportunities for compounding pharmacies to reach a broader clientele, allowing for remote consultations and customized medication delivery.

The animal drug compounding market is also witnessing innovation in formulation techniques, with a focus on developing new delivery methods that enhance the palatability and efficacy of medications. The incorporation of flavoring agents, transdermal delivery systems, and sustained-release formulations are just a few examples of how compounding pharmacies are adapting to meet the evolving needs of veterinary medicine. As the market continues to grow, driven by a combination of consumer demand, technological advancements, and regulatory support, the future of animal drug compounding promises to enhance the quality of care for animals, ensuring their health and well-being.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Animal Type

  • Companion Animals
  • Livestock Animals

By Drug Type

  • Anti-Infective Agents
  • Anti-Inflammatory Agents
  • Hormones & Substitutes
  • CNS Agents
  • Other Drug Types

By Dosage Form

  • Oral (Tablets, Capsules, Liquids, Other Oral Dosage Forms)
  • Topical (Ointments, Creams, Gels, Sprays)
  • Injectable
  • Other Dosage Forms

By Distribution Channel

  • Veterinary Hospitals Pharmacies
  • Compounding Pharmacies
  • Other Distribution Channels
  • COMPANIES PROFILED
  • AVRIO Pharmacy
  • New Era Pharmacy
  • NexGen Pharmaceuticals
  • Pace Pharmacy
  • SaveWay Compounding Pharmacy
  • ScriptWorks
  • SCIRx Pharmacy
  • Summit Veterinary Pharmacy Ltd.
  • Triangle Compounding Pharmacy
  • The Pet Apothecary
  • Veterinary Pharmaceutical Solutions
  • Veterinary Specialty Pharmacy
  • Wedgewood Pharmacy.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. ANIMAL DRUG COMPOUNDING INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Animal Type
    • 3.7.2 Market Attractiveness Analysis By Drug Type
    • 3.7.3 Market Attractiveness Analysis By Dosage Form
    • 3.7.4 Market Attractiveness Analysis By Distribution Channel
    • 3.7.5 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ANIMAL DRUG COMPOUNDING MARKET ANALYSIS BY ANIMAL TYPE

  • 5.1. Overview By Animal Type
  • 5.2. Historical and Forecast Data Analysis By Animal Type
  • 5.3. Companion Animals Historic and Forecast Sales By Regions
  • 5.4. Livestock Animals Historic and Forecast Sales By Regions

6. GLOBAL ANIMAL DRUG COMPOUNDING MARKET ANALYSIS BY DRUG TYPE

  • 6.1. Overview By Drug Type
  • 6.2. Historical and Forecast Data Analysis By Drug Type
  • 6.3. Anti-Infective Agents Historic and Forecast Sales By Regions
  • 6.4. Anti-Inflammatory Agents Historic and Forecast Sales By Regions
  • 6.5. Hormones & Substitutes Historic and Forecast Sales By Regions
  • 6.6. CNS Agents Historic and Forecast Sales By Regions
  • 6.7. Other Drug Types Historic and Forecast Sales By Regions

7. GLOBAL ANIMAL DRUG COMPOUNDING MARKET ANALYSIS BY DOSAGE FORM

  • 7.1. Overview By Dosage Form
  • 7.2. Historical and Forecast Data Analysis By Dosage Form
  • 7.3. Oral (Tablets, Capsules, Liquids, Other Oral Dosage Forms) Historic and Forecast Sales By Regions
  • 7.4. Topical (Ointments, Creams, Gels, Sprays) Historic and Forecast Sales By Regions
  • 7.5. Injectable Historic and Forecast Sales By Regions
  • 7.6. Other Dosage Forms Historic and Forecast Sales By Regions

8. GLOBAL ANIMAL DRUG COMPOUNDING MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 8.1. Overview By Distribution Channel
  • 8.2. Historical and Forecast Data Analysis By Distribution Channel
  • 8.3. Veterinary Hospitals Pharmacies Historic and Forecast Sales By Regions
  • 8.4. Compounding Pharmacies Historic and Forecast Sales By Regions
  • 8.5. Other Distribution Channels Historic and Forecast Sales By Regions

9. GLOBAL ANIMAL DRUG COMPOUNDING MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE ANIMAL DRUG COMPOUNDING COMPANIES

  • 10.1. Animal Drug Compounding Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF ANIMAL DRUG COMPOUNDING INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. AVRIO Pharmacy
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. New Era Pharmacy
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. NexGen Pharmaceuticals
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Pace Pharmacy
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. SaveWay Compounding Pharmacy
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. ScriptWorks
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. SCIRx Pharmacy
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Summit Veterinary Pharmacy Ltd.
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Triangle Compounding Pharmacy
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. The Pet Apothecary
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. Veterinary Pharmaceutical Solutions
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. Veterinary Specialty Pharmacy
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments
  • 11.15. Wedgewood Pharmacy
    • 11.15.1 Company Overview
    • 11.15.2 Company Revenue
    • 11.15.3 Products
    • 11.15.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of privcompanies